Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cervical cancer screening

04.11.2003


No proven benefit of detection of human papillomavirus alone compared with the conventional Pap smear

Under the aegis of the French Society of Clinical Cytology, physicians at the Institut Curie have evaluated the relevance of the papillomavirus detection test, Hybrid Capture‚ II, in screening for cervical cancer, the second most common cancer in women worldwide. They have shown that this test cannot replace cytological analysis of the cervical smear.
For the first time a learned society, the French Society of Clinical Cytology, has organized a multicenter, national study in general practice. Cervical cancer screening is one of 70 priority measures in France’s Cancer Plan, and an important goal is to establish a test that combines reliability, feasibility and affordability. This work was published in the October 2003 issue of the American Journal of Clinical Pathology.


Cervical cancer is the second most common cancer in women, with 465 000 new cases and 200 000 deaths worldwide every year. In France, 3 387 new cases and 1 000 deaths were recorded in 2000. Cervical cancer affects women in all age ranges, from 25 years upwards.

Cervical cancer screening: a national priority

Early detection of cervical cancer through intensified screening is one of the 70 measures of the Cancer Plan launched in France by the President of the Republic. Screening is based on the cervical smear test. In this simple and painless test, cells are collected from the surface of the cervix and are examined under the microscope for any anomaly suggestive of lesions that are precancerous or cancerous. It should be performed every three years.

The Cancer Plan is intended to broaden availability of the smear test (family planning, occupational medicine...) to women who do not have a gynecologist, so as to intensify information actions and facilitate testing for papillomavirus infection.
In France, generalization of the smear test has already led to a reduction in the incidence of cervical cancer: the number of cases decreased from 5 992 in 1975 to 3 387 in 2000, i.e. a 46 % decrease in 25 years.

This incidence though is still high, possibly due to the fact that the female population is not fully covered and also because some women develop cervical cancer despite regular smear tests, which clearly have shortcomings (false-negatives, absence of abnormal cells in the area of the smear…). Screening should be improved by the implementation of more sensitive tests.

Comparison of detection of HPV and cytologic analysis

Close to 90% of cervical cancers develop from pre-invasive lesions due to a human papillomavirus (HPV). The efficiency of screening could be improved by the inclusion of testing for HPV.

Under the aegis of the French Society of Clinical Cytology, physicians of the Institut Curie, coordinated by Dr Béatrix Cochand-Priollet (1) have evaluated the efficiency and relevance of the Hybrid Capture‚ II papillomavirus DNA test (HC-II) (2). This test performed on the cervical smear detects papillomavirus DNA and distinguishes high-risk from low-risk HPVs.

By comparing cytologic analyses and the HC-II test in 1 785 patients, the Institut Curie physicians have shown that the HC-II test performed alone is less sensitive than cytologic analysis of a cervical smear.

In conclusion, comparative analysis of the sensitivity and specificity of the HC-II technique and of the conventional Pap smear reveals no advantage of HPV detection alone in the framework of cervical cancer screening.

It is therefore unlikely that the HC-II test will replace cytologic analysis, but it could in certain cases be complementary. Further studies are needed to define the role of the HC-II test in cervical cancer screening and follow-up.


Note

(1) Dr Béatrix Cochand-Priollet works in the Pathological Anatomy and Cytology Department of the Hôpital Lariboisière.
(2) This test is manufactured by Digene“ (Gaithersburg, USA).

Catherine Goupillon | Institut Curie

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

What the world's tiniest 'monster truck' reveals

23.08.2017 | Life Sciences

Treating arthritis with algae

23.08.2017 | Life Sciences

Witnessing turbulent motion in the atmosphere of a distant star

23.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>